These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 16752296

  • 21. Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
    Hegde SS, Difuntorum S, Skinner R, Trumbull J, Krause KM.
    J Antimicrob Chemother; 2009 Apr; 63(4):763-6. PubMed ID: 19155225
    [Abstract] [Full Text] [Related]

  • 22. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A, Cirioni O, Ghiselli R, Dell'Acqua G, Orlando F, D'Amato G, Mocchegiani F, Silvestri C, Del Prete MS, Rocchi M, Balaban N, Saba V, Scalise G.
    Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection.
    Yanagihara K, Ohnishi Y, Morinaga Y, Nakamura S, Kurihara S, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Yamada Y, Kohno S, Kamihira S.
    Int J Antimicrob Agents; 2008 Nov; 32(5):401-4. PubMed ID: 18715761
    [Abstract] [Full Text] [Related]

  • 24. Cortical allograft as a vehicle for antibiotic delivery.
    Witsø E, Persen L, Benum P, Bergh K.
    Acta Orthop; 2005 Aug; 76(4):481-6. PubMed ID: 16195062
    [Abstract] [Full Text] [Related]

  • 25. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
    Kim JY, Kim SY.
    Invest Ophthalmol Vis Sci; 2011 Mar 25; 52(3):1742-7. PubMed ID: 21169530
    [Abstract] [Full Text] [Related]

  • 26. Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
    Ferrer C, Rodríguez A, Abad JL, Fernandez J, Alió JL.
    Br J Ophthalmol; 2008 May 25; 92(5):678-82. PubMed ID: 18211926
    [Abstract] [Full Text] [Related]

  • 27. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    Sacar M, Goksin I, Baltalarli A, Turgut H, Sacar S, Onem G, Ozcan V, Adali F.
    J Surg Res; 2005 Dec 25; 129(2):329-34. PubMed ID: 16360378
    [Abstract] [Full Text] [Related]

  • 28. Treatment of experimental osteomyelitis by liposomal antibiotics.
    Kadry AA, Al-Suwayeh SA, Abd-Allah AR, Bayomi MA.
    J Antimicrob Chemother; 2004 Dec 25; 54(6):1103-8. PubMed ID: 15486079
    [Abstract] [Full Text] [Related]

  • 29. Hyperbaric oxygen as adjunctive therapy in experimental mediastinitis.
    Turhan V, Sacar S, Uzun G, Sacar M, Yildiz S, Ceran N, Gorur R, Oncul O.
    J Surg Res; 2009 Jul 25; 155(1):111-5. PubMed ID: 19181335
    [Abstract] [Full Text] [Related]

  • 30. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
    Keeling WB, Myers AR, Stone PA, Heller L, Widen R, Back MR, Johnson BL, Bandyk DF, Shames ML.
    J Surg Res; 2009 Dec 25; 157(2):223-6. PubMed ID: 19560786
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
    Gracia E, Laclériga A, Monzón M, Leiva J, Oteiza C, Amorena B.
    J Surg Res; 1998 Oct 25; 79(2):146-53. PubMed ID: 9758730
    [Abstract] [Full Text] [Related]

  • 33. Therapy with hyperbaric oxygen and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats.
    Mendel V, Reichert B, Simanowski HJ, Scholz HC.
    Undersea Hyperb Med; 1999 Oct 25; 26(3):169-74. PubMed ID: 10485518
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.
    Daver NG, Shelburne SA, Atmar RL, Giordano TP, Stager CE, Reitman CA, White AC.
    J Infect; 2007 Jun 25; 54(6):539-44. PubMed ID: 17198732
    [Abstract] [Full Text] [Related]

  • 36. Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus.
    Daurel C, Prunier AL, Chau F, Garry L, Leclercq R, Fantin B.
    FEMS Immunol Med Microbiol; 2007 Nov 25; 51(2):344-9. PubMed ID: 17714489
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.
    Murillo O, Pachón ME, Euba G, Verdaguer R, Tubau F, Cabellos C, Cabo J, Gudiol F, Ariza J.
    J Infect; 2009 Mar 25; 58(3):220-6. PubMed ID: 19217166
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
    Jhanji V, Sharma N, Satpathy G, Titiyal J.
    J Cataract Refract Surg; 2007 Aug 25; 33(8):1488-9. PubMed ID: 17662450
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.